QuantalX Receives FDA De Novo Clearance for Delphi-MD, Establishing a New Modality of Brain Function Assessment

QuantalX Receives FDA De Novo Clearance for Delphi-MD, Establishing a New Modality of Brain Function Assessment

“By unlocking direct insight into how the brain is functioning, Delphi-MD gives clinicians an essential piece…

Continue Reading
QuantalX Secures FDA Clearance for its breakthrough Delphi stimulator, advancing direct brain health diagnosis at the point of care

QuantalX Secures FDA Clearance for its breakthrough Delphi stimulator, advancing direct brain health diagnosis at the point of care

The Delphi-MD platform enables accurate, early detection of brain abnormalities across a wide range of conditions,…

Continue Reading
QuantalX Partners with Sheba Longevity Center to Advance Brain Health Across Lifespan

QuantalX Partners with Sheba Longevity Center to Advance Brain Health Across Lifespan

NEW YORK, May 21, 2024 /PRNewswire/ — QuantalX Neuroscience, a leading medical device company specializing in…

Continue Reading